Reference 2018-743

REF:           2018-743

Subject:       Psoriatic Arthritis and Ankylosing Spondylitis

 

Request:

1. How many new patients have been diagnosed with Psoriatic arthritis in the last 12 months and how many in each hospital within the trust

2. How many of the newly diagnosed patients with Psoriatic arthritis patients are treated with biologic therapy (disease modifying therapy) to include numbers for:

  • adalimumab
  • apremilast
  • certolizumab
  • etanercept
  • golimumab
  • infliximab
  • secukinumab
  • ustekinumab
  • ixekizumab
  • tofacitinib

3. Are clinics held specifically for Psoriatic Arthritis, if so, how many and at which hospitals within the trust?5. How many of the newly diagnosed patients with Ankylosing Spondylitis arthritis are treated with biologic therapy (disease modifying therapy) to include numbers for:

4. How many new patients have been diagnosed with Ankylosing spondyltiis in the last 12 months and how many in each hospital within the trust?

5. How many of the newly diagnosed patients with Ankylosing Spondylitis arthritis are treated with biologic therapy (disease modifying therapy) to include numbers for:

  • Etanercept
  • Infliximab
  • Adalimumab
  • Golimumab
  • Certolizumab
  • Secukinumab

6. Are clinics held specifically for Ankylosing spondyltiis if so how many and at which hospitals

 

 

Response: 

1. How many new patients have been diagnosed with Psoriatic arthritis in the last 12 months and how many in each hospital within the trust? Please find this information attached.

2018-743 – FOI Request – Psoriatic Arthritis and Ankylosing Spondylitis [12 kb] MS Excel

2. How many of the newly diagnosed patients with Psoriatic arthritis patients are treated with biologic therapy (disease modifying therapy) to include numbers for:

• adalimumab

• apremilast

• certolizumab

• etanercept

• golimumab

• infliximab

• secukinumab

• ustekinumab

• ixekizumab

• tofacitinib

3. Are clinics held specifically for Psoriatic Arthritis, if so, how many and at which hospitals within the trust? No.
4. How many new patients have been diagnosed with Ankylosing spondyltiis in the last 12 months and how many in each hospital within the trust? Please refer to the answer for question one.
5. How many of the newly diagnosed patients with Ankylosing Spondylitis arthritis are treated with biologic therapy (disease modifying therapy) to include numbers for:

• Etanercept

• Infliximab

• Adalimumab

• Golimumab

• Certolizumab

• Secukinumab

6. Are clinics held specifically for Ankylosing spondyltiis if so how many and at which hospitals? No.